Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c38c601c00ef5aa9220a6350e54fed0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_708279867d2eff19d2706b146dabe1c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b1d6003aaec0e2d97a35f1511dfb111 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-51 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-285 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
1996-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95e3fba32f3b24b1bedca8aa366b2fc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff4ef1a84d8ed447b8e8f8483ab2d62f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3537e2a44cee837e06a4220107645a5 |
publicationDate |
1997-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9720934-A1 |
titleOfInvention |
Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
abstract |
Transferrin binding proteins from Pasteurella haemolytica and nucleic acid molecules encoding the proteins are disclosed. Antibodies against the proteins are disclosed. The invention also relates to vaccines containing the proteins of the invention. The invention also provides methods for identifying substances which affect the binding of transferrin to the proteins and methods for screening for agonists or antagonists of the binding of the proteins and transferrin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4074830-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6887686-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0173080-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0173080-A3 |
priorityDate |
1995-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |